soul trial oral semaglutide cardiovascular outcomes nejm 2024 2025 Oral Semaglutide's Impact on Cardiovascular Events in Type 2 Diabetes Patients with Cardiovascular and Kidney Disease: SOUL Trial Results Emily Kronau, PharmD, MBA (@Phar_em_D)

Recent literature is cited on patients undergoing upper endoscopy with no predictability regarding holding the drug and finding retained gastric contents

Get a Mandibular Advancement Device or CPAP to reduce snoring and prevent Sleep Apnea

Furthermore, Zn supplementation was effective in reducing ethanol-induced hepatic nitration and depletion of Zn, thereby protecting the liver from alcohol-induced injury [133]

Dose escalation is the standard clinical approach, yet many patients reach a ceiling dose or experience side effects that limit further increases

Beyond its known uses for diabetes and weight management, many people have noticed a decreased desire to drink alcohol